grant

Utilising Circulating Tumour DNA (ctDNA) to optimise the adjuvant therapy and follow-up of patients with locally advanced rectal cancer [ 2017 - 2022 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1124377]

Researchers: Prof Peter Gibbs (Principal investigator) ,  Prof Bert Vogelstein

Brief description The management of patients after surgery for rectal cancer presents multilpe dilemmas; what treatment should be given and to which patients? Our initial studies in colorectal cancer patients demonstrate that a novel blood biomarker (circulating tumour DNA) can accurately predict patient risk of recurrence and with serial samples, can indicate whether chemotherapy is being effective. During follow-up changes in this biomarker promise to be a specific and very early indicator of cancer recurrence.

Funding Amount $AUD 1,350,907.62

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]